Loading...
Metformin treatment reduces temozolomide resistance of glioblastoma cells
It has been reported that metformin acts synergistically with temozolomide (TMZ) to inhibit proliferation of glioma cells including glioblastoma multiforme (GBM). However, the molecular mechanism underlying how metformin exerts its anti-cancer effects remains elusive. We used a combined experimental...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5346677/ https://ncbi.nlm.nih.gov/pubmed/27791206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12859 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|